|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 39/42 | |||
| C07K 16/10 | |||
| C07K 16/46 | |||
| A61K 39/00 |
| (11) | Number of the document | 3352791 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16778163.2 |
| Date of filing the European patent application | 2016-09-24 | |
| (97) | Date of publication of the European application | 2018-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/053599 |
| Date | 2016-09-24 |
| (87) | Number | WO 2017/053906 |
| Date | 2017-03-30 |
| (30) | Number | Date | Country code |
| 201562232279 P | 2015-09-24 | US |
| (72) |
VIGNEAULT, Francois, US
BRIGGS, Adrian Wrangham, US
GOLDFLESS, Stephen Jacob, US
TIMBERLAKE, Sonia, US
|
| (73) |
AbVitro LLC,
400 Dexter Avenue North, Suite 1200, Seattle, WA 98109,
US
|
| (54) | HIV ANTIBODY COMPOSITIONS AND METHODS OF USE |
| HIV ANTIBODY COMPOSITIONS AND METHODS OF USE |